e8-k
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report: December 3, 2001

THE DIAL CORPORATION
(Exact Name of Registrant as Specified in its Charter)

DELAWARE
(State or Other Jurisdiction of
Incorporation or Organization)
15501 NORTH DIAL BOULEVARD
SCOTTSDALE, ARIZONA
(Address of Principal Executive Offices)

51-0374887
(I.R.S. Employer
Identification No.)
85260-1619
(Zip Code)

Registrant's Telephone Number, Including Area Code (480) 754-3425


 

ITEM 5. OTHER EVENTS

On August 28, 2001 Dial sold all of the stock of its wholly-owned subsidiary, Sarah Michaels, Inc., and inventory, other operating, intellectual property and other intangible assets associated with its Specialty Personal Care business. The SPC business included the businesses conducted under the Sarah Michaels and Freeman trademarks.

Dial retained all accounts receivable and accounts payable relating to the Specialty Personal Care business generated prior to August 28, 2001.

The accompanying consolidated balance sheets, statements of consolidated operations and statements of consolidated cash flows have been prepared to reflect the historical results of continuing operations as adjusted for the reclassification of the Specialty Personal Care business as discontinued operations.

 


 

The Dial Corporation

Consolidated Balance Sheets

                                                           
      April 1,   July 1,   September 30,   December 31,   March 31,   June 30, September 29,
      2000   2000   2000   2000   2001   2001   2001
 
 
 
                                                       
Cash and cash equivalents
  $ 4,947     $ 19,852     $ 6,424     $ 6,733     $ 4,467     $ 7,977     $ 6,570  
Receivables, net of allowances
    145,433       160,943       130,457       136,041       125,642       122,414       122,419  
Inventories
    155,155       145,877       156,537       144,806       152,805       145,571       147,447  
Deferred income taxes
    13,870       12,611       12,641       16,573       16,823       17,439       19,863  
Income tax receivable
                            6,591             31,110  
Current assets of discontinued operations
    64,927       61,382       70,353       80,932       37,933       39,391        
Other current assets
    10,999       5,824       5,447       3,403       5,012       5,951       6,844  
 
 
 
Total current assets
    395,331       406,489       381,859       388,488       349,273       338,743       334,253  
Property and equipment, net
    298,398       299,186       291,209       294,924       276,988       271,349       264,067  
Deferred income taxes
    48,016       46,815       45,230       48,623       46,560       45,523       45,643  
Intangibles, net
    320,554       424,489       423,934       421,744       430,446       429,507       427,013  
Non-current assets of discontinued operations
    220,625       216,050       209,927       205,620       204,669       197,772        
Other assets
    41,086       67,699       68,075       33,318       33,958       34,476       24,514  
 
 
 
TOTAL ASSETS
  $ 1,324,010     $ 1,460,728     $ 1,420,234     $ 1,392,717     $ 1,341,894     $ 1,317,370     $ 1,095,490  
 
 
 
                                                       
 
LIABILITIES & EQUITY
                                                     
Margin Trade accounts payable
  $ 86,966     $ 113,163     $ 115,449     $ 128,093     $ 107,874     $ 109,857     $ 107,132  
Short term debt
    151,807       130,484       167,270       125,776       115,762       78,999        
Income taxes payable
    11,079       13,255       11,704       10,746             6,040        
Current liabilities of discontinued operations
    10,849       13,945       24,647       30,399       17,165       13,844        
Other current liabilities
    72,680       91,386       98,641       110,587       105,558       121,486       154,038  
 
 
 Total current liabilities
    333,381       362,233       417,711       405,601       346,359       330,226       261,170  
Long-term debt
    410,650       526,468       469,187       469,271       469,270       448,467       480,936  
Pension and other benefits
    229,008       226,824       220,447       217,035       215,455       214,340       213,455  
Other liabilities
    6,333       6,782       6,943       6,903       6,698       6,965       7,163  
 
 
 
Total liabilities
    979,372       1,122,307       1,114,288       1,098,810       1,037,782       999,998       962,724  
Common stock, $.01 par
    1,056       1,056       1,057       1,057       1,057       1,057       1,057  
Additional capital
    408,792       397,934       400,703       402,024       407,497       412,329       419,409  
Retained income (deficit)
    204,335       198,176       164,724       153,600       163,045       174,141       (14,928 )
Accumulated other comprehensive income
    (2,965 )     (3,517 )     (3,488 )     (3,465 )     (3,922 )     (3,697 )     (1,171 )
Unearned employee benefits
    (52,941 )     (41,421 )     (43,124 )     (45,128 )     (48,620 )     (51,359 )     (56,330 )
Treasury stock
    (213,639 )     (213,807 )     (213,926 )     (214,181 )     (214,945 )     (215,099 )     (215,271 )
 
 
 
Total stockholders’ equity
    344,638       338,421       305,946       293,907       304,112       317,372       132,766  
 
TOTAL LIABILITIES & EQUITY
  $ 1,324,010     $ 1,460,728     $ 1,420,234     $ 1,392,717     $ 1,341,894     $ 1,317,370     $ 1,095,490  
 
 

 


 

The Dial Corporation

Statement of Consolidated Operations

                                           
      2000
     
      First   Second   Third   Fourth   Full
      Quarter   Quarter   Quarter   Quarter   Year
     
 
 
 
 
Net Sales
  $ 346,282     $ 388,570     $ 385,624     $ 401,798     $ 1,522,274  
Costs and expenses:
                                       
 
Cost of products sold
    173,142       193,426       197,471       207,154       771,193  
 
Asset writedowns and discontinued product inventories as a result of restructuring and special charges
          6,813       3,030       676       10,519  
 
   
     
     
     
     
 
 
Total cost of products sold
    173,142       200,239       200,501       207,830       781,712  
 
Selling, general and administrative expenses
    128,502       153,952       158,128       162,945       603,527  
 
Restructuring and special charges and other asset writedowns
          3,586       3,596       235       7,417  
 
   
     
     
     
     
 
 
Total costs and expenses
    301,644       357,777       362,225       371,010       1,392,656  
 
   
     
     
     
     
 
Operating income
    44,638       30,793       23,399       30,788       129,618  
 
Interest and other expenses
    (9,639 )     (12,322 )     (13,875 )     (14,470 )     (50,306 )
 
Net Income (loss) of joint ventures
    (721 )     (3,624 )     (13,635 )     (19,634 )     (37,614 )
 
Other income (expense) — gain (loss) on special items
          6,662       4,583       (2,002 )     9,243  
 
   
     
     
     
     
 
Income (loss) from continuing operations before income taxes
    34,278       21,509       472       (5,318 )     50,941  
 
Income taxes (benefit)
    11,607       6,666       918       (2,539 )     16,652  
 
   
     
     
     
     
 
Income (loss) from continuing operations
    22,671       14,843       (446 )     (2,779 )     34,289  
Discontinued operation:
                                       
 
Loss from discontinued Specialty Personal Care segment, net of income tax
    (1,173 )     (13,714 )     (25,720 )     (4,690 )     (45,297 )
 
Loss on disposal of discontinued Specialty Personal Care segment, net of income tax
                             
 
   
     
     
     
     
 
Net Income (Loss)
  $ 21,498     $ 1,129     $ (26,166 )   $ (7,469 )   $ (11,008 )
 
   
     
     
     
     
 
Weighted average basic shares outstanding
    93,979       91,084       91,150       91,241       92,237  
 
Weighted average equivalent shares
    631       287                    
 
   
     
     
     
     
 
Weighted average diluted shares outstanding
    94,610       91,371       91,150       91,241       92,237  
Basic net income (loss) per common share:
                                       
 
Income (loss) from continuing operations
  $ 0.24     $ 0.16     $ (0.00 )   $ (0.03 )   $ 0.37  
 
Loss from discontinued operations
    (0.01 )     (0.15 )     (0.28 )     (0.05 )     (0.49 )
 
   
     
     
     
     
 
 
Basic net income (loss) per common share
  $ 0.23     $ 0.01     $ (0.29 )   $ (0.08 )   $ (0.12 )
Diluted net income (loss) per common share:
                                       
 
Income (loss) from continuing operations
  $ 0.24     $ 0.16     $ (0.00 )   $ (0.03 )   $ 0.37  
 
Loss from discontinued operations
    (0.01 )     (0.15 )     (0.28 )     (0.05 )     (0.49 )
 
   
     
     
     
     
 
 
Diluted net income (loss) per common share
  $ 0.23     $ 0.01     $ (0.29 )   $ (0.08 )   $ (0.12 )

[Additional columns below]

[Continued from above table, first column(s) repeated]

                                   
      2001
     
      First   Second   Third   Nine
      Quarter   Quarter   Quarter   Months
     
 
 
 
Net Sales
  $ 389,672     $ 416,602     $ 430,487     $ 1,236,761  
Costs and expenses:
                               
 
Cost of products sold
    198,464       209,815       211,613       619,892  
 
Asset writedowns and discontinued product inventories as a result of restructuring and special charges
                10,940       10,940  
 
   
     
     
     
 
 
Total cost of products sold
    198,464       209,815       222,553       630,832  
 
Selling, general and administrative expenses
    156,628       170,081       170,523       497,232  
 
Restructuring and special charges and other asset writedowns
                486       486  
 
   
     
     
     
 
 
Total costs and expenses
    355,092       379,896       393,562       1,128,550  
 
   
     
     
     
 
Operating income
    34,580       36,706       36,925       108,211  
 
Interest and other expenses
    (13,872 )     (12,023 )     (11,934 )     (37,829 )
 
Net income (loss) of joint ventures
    2,000       4       986       2,990  
 
Other income (expense) — gain (loss) on special items
                       
 
   
     
     
     
 
Income (loss) from continuing operations before income taxes
    22,708       24,687       25,977       73,372  
 
Income taxes (benefit)
    8,013       8,728       12,114       28,855  
 
   
     
     
     
 
Income (loss) from continuing operations
    14,695       15,959       13,863       44,517  
Discontinued operation:
                               
 
Loss from discontinued Specialty Personal Care segment, net of income tax
    (1,597 )     (1,218 )     (876 )     (3,691 )
 
Loss on disposal of discontinued Specialty Personal Care segment, net of income tax
                (198,403 )     (198,403 )
 
   
     
     
     
 
Net Income (Loss)
  $ 13,098     $ 14,741     $ (185,416 )   $ (157,577 )
 
   
     
     
     
 
Weighted average basic shares outstanding
    91,291       91,368       91,494       91,385  
 
Weighted average equivalent shares
    294       442              
 
   
     
     
     
 
Weighted average diluted shares outstanding
    91,585       91,810       91,494       91,385  
Basic net income (loss) per common share:
                               
 
Income (loss) from continuing operations
  $ 0.16     $ 0.17     $ 0.15     $ 0.49  
 
Loss from discontinued operations
    (0.02 )     (0.01 )     (2.18 )     (2.21 )
 
   
     
     
     
 
 
Basic net income (loss) per common share
  $ 0.14     $ 0.16     $ (2.03 )   $ (1.72 )
Diluted net income (loss) per common share:
                               
 
Income (loss) from continuing operations
  $ 0.16     $ 0.17     $ 0.15     $ 0.49  
 
Loss from discontinued operations
    (0.02 )     (0.01 )     (2.18 )     (2.21 )
 
   
     
     
     
 
 
Diluted net income (loss) per common share
  $ 0.14     $ 0.16     $ (2.03 )   $ (1.72 )

 


 

The Dial Corporation

Statement of Consolidated Cash Flows

                                             
        2000
       
        First   Second   Third   Fourth   Full
        Quarter   Quarter   Quarter   Quarter   Year
       
 
 
 
 
Net income (loss)
  $ 21,498     $ 1,129     $ (26,166 )   $ (7,469 )   $ (11,008 )
Adjustments to reconcile net income to net cash provided (used) by operating activities:
                                       
Discontinued operations, net of tax
    1,173       13,714       25,720       4,690       45,297  
Special and restructuring charges
          10,399       17,760       20,247       48,406  
Depreciation
    9,259       9,742       9,789       10,918       39,708  
Amortization
    1,714       1,928       2,295       2,361       8,298  
Deferred income taxes
    4,645       3,952       (183 )     (6,538 )     1,876  
Gain (loss) — special items
          (6,662 )     (4,583 )     2,002       (9,243 )
Change in operating assets and liabilities:
                                       
 
Receivables
    5,977       (13,901 )     30,486       (5,584 )     16,978  
 
Inventories
    (11,229 )     12,441       (10,712 )     10,324       824  
 
Trade accounts payable
    (32,502 )     24,082       2,337       12,642       6,559  
 
Income taxes payable
    (33,851 )     2,781       (1,551 )     (958 )     (33,579 )
 
Other assets and liabilities, net
    (9,446 )     9,023       (3,868 )     15,745       11,454  
 
   
     
     
     
     
 
Net cash provided (used) by operating activities
    (42,762 )     68,628       41,324       58,380       125,570  
CASH FLOWS PROVIDED (USED) BY INVESTING ACTIVITIES:
                                       
Capital expenditures
    (4,608 )     (11,876 )     (9,497 )     (16,107 )     (42,088 )
Investment in and loans to joint ventures
    (3,264 )     (22,810 )     (1,136 )     13,720       (13,490 )
Acquisition of business, net of cash acquired
          (116,836 )     (2,237 )     (79 )     (119,152 )
Proceeds from disposition of discontinued operation
                             
Investments in and transfers from discontinued operation
    11,627       (3,229 )     (16,127 )     (5,999 )     (13,728 )
Proceeds from sale of assets
    (1 )     13,644       1,696       (4,381 )     10,958  
 
   
     
     
     
     
 
Net cash provided (used) by investing activities
    3,754       (141,107 )     (27,301 )     (12,846 )     (177,500 )
CASH FLOWS PROVIDED (USED) BY FINANCING ACTIVITIES:
                                       
Net change in long-term debt
    109,699       115,818       (57,281 )     84       168,320  
Common stock purchased for treasury
    (83,143 )           (111 )     110       (83,144 )
Net change in short-term debt
    91,644       (21,323 )     36,786       (41,494 )     65,613  
Dividends paid on common stock
    (7,533 )     (7,287 )     (7,293 )     (3,649 )     (25,762 )
Cash proceeds from stock options
    526       176       448       (276 )     874  
Net change in receivables sold
    (73,177 )                       (73,177 )
 
   
     
     
     
     
 
Net cash provided (used) by financing activities
    38,016       87,384       (27,451 )     (45,225 )     52,724  
 
   
     
     
     
     
 
Net increase (decrease) in cash and cash equivalents
    (992 )     14,905       (13,428 )     309       794  
Cash and cash equivalents, beginning of period
    5,939       4,947       19,852       6,424       5,939  
 
   
     
     
     
     
 
CASH AND CASH EQUIVALENTS, END OF PERIOD
  $ 4,947     $ 19,852     $ 6,424     $ 6,733     $ 6,733  
 
   
     
     
     
     
 

[Additional columns below]

[Continued from above table, first column(s) repeated]

                                     
        2001
       
        First   Second   Third   Nine
        Quarter   Quarter   Quarter   Months
       
 
 
 
Net income (loss)
  $ 13,098     $ 14,741     $ (185,416 )   $ (157,577 )
Adjustments to reconcile net income to net cash provided (used) by operating activities:
                               
Discontinued operations, net of tax
    1,597       1,218       199,279       202,094  
Special and restructuring charges
                11,787       11,787  
 
Depreciation
    9,761       9,578       9,857       29,196  
Amortization
    2,430       2,486       2,570       7,486  
Deferred income taxes
    1,100       494       (2,189 )     (595 )
Gain (loss) — special items
                       
Change in operating assets and liabilities:
                               
 
Receivables
    10,399       3,228       (214 )     13,413  
 
Inventories
    (7,999 )     7,234       (2,391 )     (3,156 )
 
Trade accounts payable
    (20,219 )     1,983       (2,725 )     (20,961 )
 
Income taxes payable
    (17,337 )     12,631       (37,150 )     (41,856 )
 
Other assets and liabilities, net
    (8,336 )     14,122       38,338       44,124  
 
   
     
     
     
 
Net cash provided (used) by operating activities
    (15,506 )     67,715       31,746       83,955  
CASH FLOWS PROVIDED (USED) BY INVESTING ACTIVITIES:
                               
Capital expenditures
    (3,091 )     (6,489 )     (7,976 )     (17,556 )
Investment in and loans to joint ventures
                       
Acquisition of business, net of cash acquired
    (75 )                 (75 )
Proceeds from disposition of discontinued operation
                8,000       8,000  
Investments in and transfers from discontinued operation
    29,833       828       15,684       46,345  
Proceeds from sale of assets
    2       2,269       (11 )     2,260  
 
   
     
     
     
 
Net cash provided (used) by investing activities
    26,669       (3,392 )     15,697       38,974  
CASH FLOWS PROVIDED (USED) BY FINANCING ACTIVITIES:
                               
Net change in long-term debt
    (1 )     (20,803 )     32,469       11,665  
Common stock purchased for treasury
                       
Net change in short-term debt
    (10,014 )     (36,763 )     (78,999 )     (125,776 )
Dividends paid on common stock
    (3,653 )     (3,635 )     (3,662 )     (10,950 )
Cash proceeds from stock options
    239       388       1,342       1,969  
 
Net change in receivables sold
                       
 
 
   
     
     
     
 
 
Net cash provided (used) by financing activities
    (13,429 )     (60,813 )     (48,850 )     (123,092 )
 
 
   
     
     
     
     
 
 
Net increase (decrease) in cash and cash equivalents
    (2,266 )     3,510       (1,407 )     (163 )
Cash and cash equivalents, beginning of period
    6,733       4,467       7,977       6,733  
 
   
     
     
     
 
CASH AND CASH EQUIVALENTS, END OF PERIOD
  $ 4,467     $ 7,977     $ 6,570     $ 6,570  
 
   
     
     
     
 

 


 

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

The Dial Corporation
December 3, 2001

/s/ Conrad A. Conrad
Executive Vice President and Chief Financial Officer